Relationship between the nutritional status and safety and efficacy outcomes in atrial fibrillation patients aged 80 years and over receiving oral anticoagulants
- PMID: 33371946
- DOI: 10.1016/j.jjcc.2020.10.008
Relationship between the nutritional status and safety and efficacy outcomes in atrial fibrillation patients aged 80 years and over receiving oral anticoagulants
Abstract
Background: Malnutrition has been reported to be associated with worse clinical outcomes in various cardiovascular diseases. We aimed to investigate the clinical significance of the nutritional status in atrial fibrillation (AF) patients aged 80 years and over receiving oral anticoagulants (OACs), focusing on the difference between direct OACs (DOACs) and warfarin treatment.
Methods: This was a retrospective and observational study. We enrolled 332 consecutive AF patients aged 80 years and over who were treated with OACs: DOACs (n = 256) and warfarin (n = 76). A controlling nutritional status (CONUT) score was used to evaluate the nutritional status. The enrolled patients were divided into two groups based on the CONUT score: CONUT score <5 (n = 239) and CONUT score ≥5 (n = 93) groups. We investigated the relationship between the nutritional status and clinical outcomes.
Results: The CONUT score ≥5 group had significantly higher incidence of major bleeding (MB) compared to the CONUT score <5 group (4.6/100 person-years vs. 0.7/100 person-years, p < 0.01). On Cox hazard analysis, CONUT score ≥5 group was significantly associated with increased MB compared with the CONUT score <5 group (hazard ratio: 5.80, 95% confidence interval: 1.44-23.33, p = 0.013). In the DOAC group, the incidence of MB did not differ between the CONUT score ≥5 and CONUT score <5 groups (p = 0.54). In the warfarin group, MB occurred more frequently in the CONUT score ≥5 group than CONUT score <5 group (p < 0.01). There was no significant difference in the incidence of thromboembolic events between the CONUT score ≥5 and CONUT score <5 groups in both the DOAC and warfarin groups.
Conclusions: The prognostic values of the nutritional status based on the CONUT score for MB differed between AF patients aged 80 years and over receiving DOACs and those receiving warfarin. It may be favorable to use DOACs to avoid bleeding events in those with malnutrition.
Keywords: Atrial fibrillation; Nutritional status; Oral anticoagulants.
Copyright © 2020 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Glycemic status and risks of thromboembolism and major bleeding in patients with atrial fibrillation.Cardiovasc Diabetol. 2020 Mar 10;19(1):30. doi: 10.1186/s12933-020-01005-8. Cardiovasc Diabetol. 2020. PMID: 32156277 Free PMC article.
-
Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.J Cardiovasc Pharmacol Ther. 2019 Sep;24(5):428-434. doi: 10.1177/1074248419841634. Epub 2019 Apr 29. J Cardiovasc Pharmacol Ther. 2019. PMID: 31035795
-
Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.Circulation. 2018 Oct 2;138(14):1402-1411. doi: 10.1161/CIRCULATIONAHA.117.031457. Circulation. 2018. PMID: 29794081
-
Clinical profile of direct oral anticoagulants versus vitamin K anticoagulants in octogenarians with atrial fibrillation: a multicentre propensity score matched real-world cohort study.J Thromb Thrombolysis. 2020 Jan;49(1):42-53. doi: 10.1007/s11239-019-01923-9. J Thromb Thrombolysis. 2020. PMID: 31385163 Clinical Trial.
-
Lower Major Bleeding Rates with Direct Oral Anticoagulants in Catheter Ablation of Atrial Fibrillation: an Updated Meta-analysis of Randomized Controlled Studies.Cardiovasc Drugs Ther. 2020 Apr;34(2):209-214. doi: 10.1007/s10557-020-06947-5. Cardiovasc Drugs Ther. 2020. PMID: 32080786 Review.
Cited by
-
Trends in Anticoagulant Utilization and Clinical Outcomes for Cancer-Associated Thrombosis: A Multicenter Cohort Study in Thailand's Upper-Middle-Income Country Setting.JCO Glob Oncol. 2024 Feb;10:e2300353. doi: 10.1200/GO.23.00353. JCO Glob Oncol. 2024. PMID: 38422463 Free PMC article.
-
Impaired brain activity in patients with persistent atrial fibrillation assessed by near-infrared spectroscopy and its changes after catheter ablation.Sci Rep. 2022 May 12;12(1):7866. doi: 10.1038/s41598-022-12097-5. Sci Rep. 2022. PMID: 35550598 Free PMC article.
-
Poor clinical outcomes associated to multimorbidity, frailty and malnutrition in patients with atrial fibrillation.J Nutr Health Aging. 2025 Jan;29(1):100430. doi: 10.1016/j.jnha.2024.100430. Epub 2024 Nov 29. J Nutr Health Aging. 2025. PMID: 39615399 Free PMC article.
-
Inappropriate Combined Antiplatelet and Anticoagulant Therapy in Older Patients with Atrial Fibrillation: Trend over Time (2009-18).Drugs Aging. 2023 Mar;40(3):273-283. doi: 10.1007/s40266-023-01006-8. Epub 2023 Feb 23. Drugs Aging. 2023. PMID: 36821028
-
Low alanine aminotransferase levels are independently associated with mortality risk in patients with atrial fibrillation.Sci Rep. 2022 Jul 16;12(1):12183. doi: 10.1038/s41598-022-16435-5. Sci Rep. 2022. PMID: 35842444 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous